King, Bridget, Bojesen, Kirsten Borup, Crisp, Charlotte, de Bartolomeis, Andrea, de Haan, Lieuwe, de la Fuente-Sandoval, Camilo, Dempster, Kara, Drake, Richard J., Dazzan, Paola, Ebdrup, Bjørn H., and others. (2026) Neurometabolites and Antipsychotic Response in Psychosis. JAMA Psychiatry, 83 (9). pp. 939-948. ISSN 2168-622X. (doi:10.1001/jamapsychiatry.2026.1674) (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided) (KAR id:117726)
| The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided. | |
| Contact us about this publication | |
| Official URL: https://doi.org/10.1001/jamapsychiatry.2026.1674 |
|
Abstract
Importance
Revealing neurobiological markers of antipsychotic nonresponse in psychosis may aid outcome prediction and inform novel treatment targets.
Objective
To examine differences in neurometabolites in antipsychotic nonresponsive compared to antipsychotic-responsive psychosis using individual participant data and meta-analysis.
Data Sources
Web of Science was searched for studies published between January 1, 1980, and November 1, 2025. Authors of 21 eligible studies identified before August 2024 were invited to contribute individual participant data.
Study Selection
Eighteen studies examining neurometabolites by treatment response in psychosis contributed individual participant data for the mega-analysis. These studies plus a further 5 studies were included in the meta-analyses of standardized mean differences and variability.
Data Extraction and Synthesis
Individual participant data were analyzed using linear mixed models with study as a random effect. Subgroup analyses examined prospective designs and treatment-resistant samples. Published group means and standard deviations were extracted for meta-analyses.
Main Outcomes and Measures
Group differences in glutamate, glutamate plus glutamine, choline, myo-inositol, N-acetylaspartate, γ-aminobutyric acid, and glutathione in the medial frontal cortex, dorsolateral prefrontal cortex, thalamus, and basal ganglia.
Results
The mega-analysis included 1189 participants from 18 studies; of these, 476 were treatment nonresponders (mean [SD] age, 33.0 [12.5] years; 340 male), 427 were treatment responders (mean [SD] age, 30.3 [11.5] years; 299 male), and 286 were healthy control individuals (mean [SD] age, 31.0 [12.5] years; 170 male). Compared with the antipsychotic response group, nonresponders showed elevations in medial frontal glutamate (Glass Δ = 0.21; P = .02), glutamate plus glutamine (Glass Δ = 0.29; P = .002), choline (Glass Δ = 0.22; P = .03), and myo-inositol (Glass Δ = 0.35; P = .001); similar elevations were observed relative to control individuals. Elevated medial frontal glutamate plus glutamine in antipsychotic nonresponders compared with responders was also observed prospectively in first-episode psychosis (Glass Δ = 0.41; P = .002), whereas myo-inositol elevations were greatest in individuals meeting criteria for treatment-resistance (Glass Δ = 0.64; P = .001). The meta-analysis of 23 studies (1844 participants) also showed elevated medial frontal choline and myo-inositol in antipsychotic nonresponse compared with response.
Conclusions and Relevance
These findings provide evidence of an association between antipsychotic nonresponse in psychosis with elevations in medial frontal glutamate, choline, and myo-inositol. The presence of elevations in these markers supports the continued investigation of glutamate-acting and inflammatory pathway–associated interventions for psychosis and schizophrenia.
| Item Type: | Article |
|---|---|
| DOI/Identification number: | 10.1001/jamapsychiatry.2026.1674 |
| Additional information: | For the purpose of open access, the author(s) has applied a Creative Commons Attribution (CC BY) licence to any Author Accepted Manuscript version arising. |
| Subjects: | R Medicine |
| Institutional Unit: | Schools > Kent and Medway Medical School |
| Former Institutional Unit: |
There are no former institutional units.
|
| Funders: | National Institute for Health Research (https://ror.org/0187kwz08) |
| Depositing User: | Ian Badger |
| Date Deposited: | 12 Nov 2026 12:21 UTC |
| Last Modified: | 12 Nov 2026 12:21 UTC |
| Resource URI: | https://kar.kent.ac.uk/id/eprint/117726 (The current URI for this page, for reference purposes) |
- Export to:
- RefWorks
- EPrints3 XML
- BibTeX
- CSV
- Depositors only (login required):

Altmetric
Altmetric